KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Total Current Liabilities (2020 - 2025)

AbCellera Biologics' Total Current Liabilities history spans 6 years, with the latest figure at $68.8 million for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities fell 13.53% year-over-year to $68.8 million, compared with a TTM value of $68.8 million through Sep 2025, down 13.53%, and an annual FY2024 reading of $76.6 million, down 35.63% over the prior year.
  • Total Current Liabilities for Q3 2025 was $68.8 million at AbCellera Biologics, up from $67.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $221.1 million in Q2 2022, with the low at $49.5 million in Q3 2021.
  • Average Total Current Liabilities over 5 years is $103.6 million, with a median of $89.6 million recorded in 2023.
  • Year-over-year, Total Current Liabilities skyrocketed 217.01% in 2022 and then plummeted 58.02% in 2023.
  • Tracing ABCL's Total Current Liabilities over 5 years: stood at $120.7 million in 2021, then decreased by 1.95% to $118.3 million in 2022, then grew by 0.59% to $119.0 million in 2023, then tumbled by 35.63% to $76.6 million in 2024, then dropped by 10.19% to $68.8 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Total Current Liabilities are $68.8 million (Q3 2025), $67.0 million (Q2 2025), and $75.4 million (Q1 2025).